Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126015071 | 12601507 | 1 | I | 20160720 | 20160728 | 20160728 | EXP | DE-DRREDDYS-GER/GER/16/0081767 | DR REDDYS | 31.00 | YR | F | Y | 48.00000 | KG | 20160728 | MD | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126015071 | 12601507 | 1 | PS | SERTRALINE | SERTRALINE HYDROCHLORIDE | 1 | Oral | U | U | UNKNOWN | 76442 | 75 | MG | QD | |||||
| 126015071 | 12601507 | 2 | C | Pantoprazole | PANTOPRAZOLE SODIUM | 1 | Oral | 0 | |||||||||||
| 126015071 | 12601507 | 3 | C | MCP | METOCLOPRAMIDE HYDROCHLORIDE | 1 | Intravenous drip | 0 | |||||||||||
| 126015071 | 12601507 | 4 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | 0 | 20 | MG | |||||||||
| 126015071 | 12601507 | 5 | C | glucose 5% infusion | 2 | Intravenous drip | 0 | ||||||||||||
| 126015071 | 12601507 | 6 | C | MIRTAZAPINE. | MIRTAZAPINE | 1 | Oral | 0 | |||||||||||
| 126015071 | 12601507 | 7 | C | Tavor 1,0 expidet | 2 | Oral | 0 | 1 | MG | QD | |||||||||
| 126015071 | 12601507 | 8 | C | Gynvital Gravida | HERBALS | 1 | Oral | 0 | .4 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126015071 | 12601507 | 1 | Anxiety disorder |
| 126015071 | 12601507 | 2 | Gastritis |
| 126015071 | 12601507 | 3 | Nausea |
| 126015071 | 12601507 | 4 | Prophylaxis against gastrointestinal ulcer |
| 126015071 | 12601507 | 5 | Nausea |
| 126015071 | 12601507 | 6 | Nausea |
| 126015071 | 12601507 | 7 | Product used for unknown indication |
| 126015071 | 12601507 | 8 | Prophylaxis of neural tube defect |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126015071 | 12601507 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126015071 | 12601507 | Cholestasis | |
| 126015071 | 12601507 | Exposure during pregnancy | |
| 126015071 | 12601507 | Gastritis | |
| 126015071 | 12601507 | HELLP syndrome | |
| 126015071 | 12601507 | Hypertension | |
| 126015071 | 12601507 | Nausea |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126015071 | 12601507 | 1 | 20150223 | 20150929 | 0 | |
| 126015071 | 12601507 | 3 | 20150529 | 20150529 | 0 | |
| 126015071 | 12601507 | 5 | 20150529 | 20150529 | 0 |